The Business Research Company’s report on the Preclinical CRO Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How have key drivers contributed to the rapid growth of the preclinical cro market?
The increasing demand for preclinical trials is expected to propel the growth of the preclinical CRO market going forward. Preclinical trials refer to any study conducted on medicine or treatment for a condition before human volunteers are used as test subjects. Preclinical studies often involve novel medical devices, prescription medications, and diagnostics, and its primary objectives are to establish a beginning, safe dose for first-in-human research and evaluate any potential toxicity of the product. Preclinical trials play a critical role in drug development, and their importance is increasing with the growing emphasis on the safety and efficacy of new drugs. For instance, in February 2024, according to IQVIA, a US-based company serving the combined industries of health information technology and clinical research reports, clinical development productivity rose in 2023, where a total of 69 novel active substances (NASs) were launched globally in 2023, 6 more than the prior year, and including 24 first-in-class launches in the U.S. Therefore, the increasing demand for preclinical trials is driving the growth of the preclinical CRO market going forward.
Access Your Free Sample of the Global Preclinical CRO Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10303&type=smp
How has the preclinical cro market size evolved, and what are the latest forecasts for its expansion?
The preclinical CRO market size has grown strongly in recent years. It will grow from$5.7 billion in 2024 to $6.26 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to demand for faster drug development, cost containment strategies, focus on core competencies, regulatory compliance requirements, globalization of clinical trials
The preclinical CRO market size is expected to see strong growth in the next few years. It will grow to “$9.06 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rise in personalized medicine, focus on rare diseases and orphan drugs, increased outsourcing in biopharmaceuticals, emphasis on biomarker research, demand for real-world evidence generation. Major trends in the forecast period include integration of artificial intelligence (AI), expansion of oncology research, advances in omics technologies, advanced in vitro and in vivo models, collaboration for translational research.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10303&type=smp
Which major companies dominate the preclinical cro market?
Major companies operating in the preclinical CRO market include Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec Co. Ltd., Medpace Holdings Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Simavita Ltd., BioEmission Technology Solutions, Altasciences Company Inc., Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd., ICON plc, Kunming Biomed International Ltd., PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc., Syngene International Limited
What trends will shape the future of the powered air-purifying respirator (papr) market?
Technological advancements are a key trend gaining popularity in the preclinical CRO market. Major companies operating in the preclinical CRO market are adopting new technologies to sustain their position in the market. For instance, in February 2023, BenchSci, a Canada-based AI solutions company for preclinical R&D, launched ASCEND, an end-to-end SaaS (software as a service) platform and for preclinical drug discovery. By gaining biological insights into the fundamental underpinnings of disease, this method seeks to speed up preclinical phase drug development pipelines. ASCEND extracts experimental data from safe internal and public external sources using BenchSci’s machine-learning technology. The platform compares experimental results using curated ontology datasets. As a result, the software can produce a map of the biological processes underpinning various diseases that are based on evidence.
Which region dominates the preclinical cro market, and what factors contribute to its leadership?
North America was the largest region in the preclinical CRO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical CRO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report
How is the preclinical cro market segmented, and which segment holds the largest share?
The preclinical CRO market covered in this report is segmented –
1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services
2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model
3) By Animal Model: Small Animal Model, Large Animal Model
4) By Model System: In Vivo, In Vitro
5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users
Subsegments:
1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies, Pharmacodynamics Studies, Drug Metabolism Studies
2) By Toxicology Testing: Acute Toxicity Testing, Chronic Toxicity Testing, Reproductive Toxicity Testing
3) By Compound Management: Sample Management, Inventory Management, Formulation Services
4) By Chemistry: Medicinal Chemistry, Analytical Chemistry, Synthetic Chemistry
5) By Safety Pharmacology: Cardiovascular Safety Studies, Central Nervous System Safety Studies, Respiratory Safety Studies
6) By Other Services: Regulatory Consulting, Project Management, Data Management Services
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10303
How is the preclinical cro market defined?
Preclinical CROs (contract research organizations) are support organizations that provide the knowledge in research and development needed to guide a drug candidate through animal testing and advance it to the clinical stage. A preclinical CRO supports new medical product producers in showing product safety and efficacy in living animals that the Food and Drug Administration (FDA) considers mirroring human anatomy most closely before entering clinical trials or being used for human care.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
